Join the Acalabrutinib group to help and get support from people like you.
Acalabrutinib News
Calquence Tablet Formulation Approved in the US Across Current indications
New formulation can be co-administered with gastric acid-reducing agents Tablet offers equivalent efficacy, safety and consistent dosing compared to current capsule 5 August 2022 – AstraZeneca’s n...
FDA Approves Calquence for Adults with Chronic Lymphocytic Leukemia
21 November 2019 – AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Calquence (acalabrutinib) for adult patients with chronic lymphocytic leukemia (CLL) or s...
FDA Approves Calquence (acalabrutinib) for Adults with Mantle Cell Lymphoma
October 31, 2017 – The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received at...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Chronic Lymphocytic Leukemia (CLL)